E S Woodle

Author PubWeight™ 74.54‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Should HLA mismatch acceptability for sensitized transplant candidates be determined at the high-resolution rather than the antigen level? Am J Transplant 2015 2.24
2 Epstein-Barr virus-induced posttransplant lymphoproliferative disorders. ASTS/ASTP EBV-PTLD Task Force and The Mayo Clinic Organized International Consensus Development Meeting. Transplantation 1999 1.70
3 Sotrastaurin, a novel small molecule inhibiting protein-kinase C: randomized phase II study in renal transplant recipients. Am J Transplant 2011 1.69
4 Ethics of a paired-kidney-exchange program. N Engl J Med 1997 1.66
5 Increased utilization of organ donors: transplantation of two recipients from single donor livers. Transplant Proc 1990 1.61
6 Donor-transmitted malignancies in organ transplantation: assessment of clinical risk. Am J Transplant 2011 1.59
7 Results of the double-blind, randomized, multicenter, phase III clinical trial of Thymoglobulin versus Atgam in the treatment of acute graft rejection episodes after renal transplantation. Transplantation 1998 1.36
8 Immunosuppression with belatacept-based, corticosteroid-avoiding regimens in de novo kidney transplant recipients. Am J Transplant 2010 1.31
9 Portal vein thrombosis and stenosis in pediatric liver transplantation. Transplantation 1996 1.27
10 Immunosuppression and Merkel cell cancer. Transplant Proc 2002 1.25
11 Posttransplant lymphoproliferative disorder: significance of central nervous system involvement. Transplant Proc 2005 1.17
12 Liver transplantation for primary or metastatic sarcoma to the liver. Am J Transplant 2006 1.16
13 Posttransplant lymphoproliferative disease in pediatric liver transplantation. Interplay between primary Epstein-Barr virus infection and immunosuppression. Transplantation 1996 1.14
14 Reducing de novo donor-specific antibody levels during acute rejection diminishes renal allograft loss. Am J Transplant 2009 1.11
15 Complications in 100 living-liver donors. Ann Surg 1998 1.07
16 Primary living-donor liver transplantation at the University of Chicago: technical aspects of the first 104 recipients. Ann Surg 2000 1.01
17 Randomized controlled pilot study of B cell-targeted induction therapy in HLA sensitized kidney transplant recipients. Am J Transplant 2013 0.97
18 The role of donor-specific HLA alloantibodies in liver transplantation. Am J Transplant 2014 0.96
19 Biliary complications in living donor liver transplantation. Transplant Proc 1997 0.95
20 Technetium-99m NGA functional hepatic imaging: preliminary clinical experience. J Nucl Med 1985 0.94
21 Skin cancer following transplantation: the Israel Penn International Transplant Tumor Registry experience. Transplant Proc 2005 0.93
22 A prospective, pilot study of early corticosteroid cessation in high-immunologic-risk patients: the Cincinnati experience. Transplant Proc 2005 0.92
23 Corticosteroid cessation 1 week following renal transplantation using tacrolimus/mycophenolate mofetil based immunosuppression. Transplant Proc 1998 0.91
24 Inhibition of T cell activation by a monoclonal antibody reactive against the alpha 3 domain of human MHC class I molecules. J Immunol 1994 0.91
25 Comparison of pancreas transplantation with portal venous and enteric exocrine drainage to the standard technique utilizing bladder drainage of exocrine secretions. Transplantation 1996 0.91
26 Efficacy of sotrastaurin plus tacrolimus after de novo kidney transplantation: randomized, phase II trial results. Am J Transplant 2013 0.90
27 Analysis of fracture prevalence in kidney-pancreas allograft recipients. J Am Soc Nephrol 1998 0.90
28 The relationship of untreated borderline infiltrates by the Banff criteria to acute rejection in renal allograft biopsies. J Am Soc Nephrol 1999 0.89
29 De novo colorectal cancer: five-year survival is markedly lower in transplant recipients compared with the general population. Transplant Proc 2005 0.88
30 Orthotopic liver transplantation in a patient with Amanita poisoning. JAMA 1985 0.88
31 Laparoscopic living donor nephrectomy for kidneys with multiple arteries. Transplant Proc 2005 0.88
32 Are concerns over right laparoscopic donor nephrectomy unwarranted? Ann Surg 2001 0.87
33 Donor kidneys with small renal cell cancers: can they be transplanted? Transplant Proc 2005 0.87
34 Helical CT examination of potential kidney donors. AJR Am J Roentgenol 1998 0.87
35 Incompatible kidney donor candidates' willingness to participate in donor-exchange and non-directed donation. Am J Transplant 2006 0.86
36 Incidence and outcome of infection by vancomycin-resistant Enterococcus following orthotopic liver transplantation. Transplantation 1998 0.86
37 Drug-induced acute interstitial nephritis in renal allografts: histopathologic features and clinical course in six patients. Am J Kidney Dis 1999 0.86
38 Laparoscopic right living donor nephrectomy. Transplant Proc 2005 0.85
39 Polyomavirus in kidney and kidney-pancreas transplantation: a defined protocol for immunosuppression reduction and histologic monitoring. Transplant Proc 2002 0.85
40 Gastric cancer in transplant recipients: detection of malignancy [correction of malignacy] by aggressive endoscopy. Transplant Proc 2002 0.85
41 Primum non nocere: avoiding harm to vulnerable wait list candidates in an indirect kidney exchange. Transplantation 2001 0.84
42 Ethical issues in increasing living kidney donations by expanding kidney paired exchange programs. Transplantation 2000 0.84
43 Human peripheral blood lymphocyte reconstituted severe combined immunodeficient (hu-PBL-SCID) mice. A model for human islet allograft rejection. Transplantation 1994 0.84
44 De novo breast cancer in renal transplant recipients. Transplant Proc 2002 0.84
45 Kinetic sensitivity of a receptor-binding radiopharmaceutical: technetium-99m galactosyl-neoglycoalbumin. J Nucl Med 1989 0.83
46 Living related liver transplantation in children: a report of the first 58 recipients at the University of Chicago. Transpl Int 1994 0.82
47 Proteasome inhibition reduces donor-specific antibody levels. Transplant Proc 2009 0.82
48 Addressing morbid obesity as a barrier to renal transplantation with laparoscopic sleeve gastrectomy. Am J Transplant 2015 0.81
49 Early steroid withdrawal does not increase risk for recurrent focal segmental glomerulosclerosis. Transplant Proc 2005 0.81
50 Activation of human T cells in vivo following treatment of transplant recipients with OKT3. Transplantation 1990 0.81
51 HLA-identical renal transplant recipients: immunosuppression, long-term complications, and survival. Transplant Proc 2001 0.80
52 Methicillin-resistant Staphylococcus aureus infection in liver transplantation: a matched controlled study. Transplant Proc 2005 0.80
53 Synchronous pancreas-kidney transplantation with portal venous and enteric exocrine drainage: outcome in 70 consecutive cases. Transplant Proc 1998 0.80
54 Pancreas transplantation with portal venous drainage and enteric exocrine drainage offers early advantages without compromising safety or allograft function. Transplant Proc 1995 0.79
55 Long-term outcome of kidney-pancreas transplant recipients with good graft function at one year. Transplantation 1996 0.79
56 Corticosteroid avoidance ameliorates lymphocele formation and wound healing complications associated with sirolimus therapy. Transplant Proc 2005 0.79
57 De novo sarcomas in solid organ transplant recipients. Transplant Proc 2002 0.79
58 Tacrolimus therapy for refractory renal allograft rejection: experience with steroid withdrawal. Transplant Proc 1997 0.79
59 Tacrolimus/mycophenolate provides superior immunosuppression relative to neoral/mycophenolate in synchronous pancreas-kidney transplantation. Transplant Proc 1998 0.79
60 Outcomes of patients with rejection post-polyomavirus nephropathy. Transplant Proc 2005 0.78
61 Hand-assisted laparoscopic live-donor nephrectomy. J Am Coll Surg 2001 0.78
62 Transmission of donor cancer into cardiothoracic transplant recipients. Surgery 2001 0.78
63 New scoring system identifies kidney outcome with radiation therapy in acute renal allograft rejection. Int J Radiat Oncol Biol Phys 2000 0.78
64 Changes in urinary cytokine mRNA profile after successful therapy for acute cellular renal allograft rejection. Transplant Proc 1995 0.78
65 Pediatric liver transplantation at the University of Chicago Hospitals. Clin Transpl 1992 0.77
66 An analysis of hepatic retransplantation in children. Transplantation 1998 0.77
67 Neurotoxicity of FK 506 in liver transplant recipients. Transplant Proc 1993 0.77
68 Coadministration of tacrolimus and mycophenolate mofetil in stable kidney transplant patients: pharmacokinetics and tolerability. J Clin Pharmacol 2000 0.77
69 Tc-NGA imaging in liver transplantation: preclinical studies. Surgery 1987 0.77
70 African American renal transplant recipients benefit from early corticosteroid withdrawal under modern immunosuppression. Transplant Proc 2005 0.77
71 Central nervous system tumors in donors: misdiagnosis carries a high morbidity and mortality. Transplant Proc 2005 0.77
72 Effect of corticosteroid withdrawal on tacrolimus and mycophenolate mofetil exposure in a randomized multicenter study. Am J Transplant 2012 0.76
73 Global cardiovascular risk under early corticosteroid cessation decreases progressively in the first year following renal transplantation. Transplant Proc 2005 0.76
74 Smooth muscle-specific actin levels in the urine of renal transplant recipients: correlation with cyclosporine or tacrolimus nephrotoxicity. Am J Kidney Dis 1999 0.76
75 T lymphocyte activation following OKT3 treatment. Curr Surg 1991 0.76
76 Use of polytetrafluoroethylene patch for temporary wound closure after pediatric liver transplantation. Transplantation 1996 0.76
77 Chemotherapy for posttransplant lymphoproliferative disorder: the Israel Penn International Transplant Tumor Registry experience. Transplant Proc 2005 0.76
78 Successful use of tacrolimus for initial rejection episodes after liver transplantation. Transplant Proc 1998 0.76
79 Of mice and men: terminal complement inhibition with anti-C5 monoclonal antibodies. Am J Transplant 2011 0.75
80 General surgery: liver transplantation. West J Med 1985 0.75
81 Regulatory approval for new antihumoral therapies: addressing the barriers. Am J Transplant 2011 0.75
82 Paired exchanges should be part of the solution to ABO incompatibility in living donor kidney transplantation. Transplantation 1998 0.75
83 Control of risk factors for cardiovascular disease in long-term renal transplant recipients. Transplant Proc 2001 0.75
84 Late complications in kidney-pancreas transplant recipients. Transplant Proc 1995 0.75
85 Combined liver and kidney transplantation in children. Transplantation 2000 0.75
86 Hepatic perfusion abnormalities after liver transplantation. Cardiovasc Intervent Radiol 1985 0.75
87 The diaphragmatic vena cava cuff in hepatic transplantation. Transplantation 1985 0.75
88 Laparoscopic live donor nephrectomy: rationale, techniques, and implications. Semin Dial 2001 0.75
89 Impact of a liberalized donor acceptance policy on liver transplantation. Transplant Proc 1997 0.75
90 Outcome of monoclonal antibody induction and anti-rejection therapy in pancreas transplantation. Transplant Proc 1996 0.75
91 Reversal of delayed hyperacute renal allograft rejection with a tacrolimus-based therapeutic regimen. Transplant Proc 1998 0.75
92 Programmed cell death signaling via cell-surface expression of a single-chain antibody transgene. Transplantation 2000 0.75
93 Retransplantation for failed hepatic allografts in children. Transplant Proc 1997 0.75
94 Aggressive needle biopsy protocol prevents loss of renal allografts to undetected rejection during early posttransplant dysfunction. Transplant Proc 1989 0.75
95 Liver transplantation at the University of Chicago. Clin Transpl 1995 0.75
96 A simple technique for experimental hepatic vein catheterization in swine. Lab Anim Sci 1986 0.75
97 Economic outcome of simultaneous pancreas kidney transplantation compared with kidney transplantation alone. Transplant Proc 2001 0.75
98 Effects of tacrolimus, mycophenolate mofetil, and cyclosporine microemulsion on rejection incidence in synchronous pancreas-kidney transplantation. Transplant Proc 1998 0.75
99 Pilot study of early corticosteroid elimination after pancreas transplantation. Transplant Proc 2005 0.75
100 Body weight alterations under early corticosteroid withdrawal and chronic corticosteroid therapy with modern immunosuppression. Transplant Proc 2005 0.75
101 Tacrolimus treatment of steroid-resistant rejection provides economic advantages compared with OKT3 therapy. Transplant Proc 1997 0.75
102 Cyclosporine versus cyclosporine microemulsion in pediatric liver transplant recipients. Transplant Proc 1998 0.75
103 Transplantation without steroids. Transplant Proc 2002 0.75
104 Construction of a single-chain antibody derived from 5H7, a monoclonal antibody specific for a death signaling domain of human class I major histocompatibility complex. Transplant Proc 1998 0.75
105 Treatment of steroid-resistant rejection with tacrolimus prior to OKT3 in liver transplant recipients. Transplant Proc 1996 0.75
106 Stapled duodenal-cystic anastomosis in pancreas transplantation. Transplantation 1988 0.75
107 Tacrolimus for primary treatment of steroid-resistant hepatic allograft rejection. Transplantation 1996 0.75
108 Orthotopic porcine liver transplantation: operative technique. J Surg Res 1985 0.75
109 Tacrolimus therapy for refractory acute renal allograft rejection: a 4-year experience with an aggressive approach. Transplant Proc 1998 0.75
110 Anesthetic, preoperative and postoperative considerations for liver transplantation in swine. Lab Anim Sci 1986 0.75
111 Inhibition of T-cell activation by an anti-human class I MHC reactive monoclonal antibody occurs at a point distal to TCR-CD3 mediated signal transduction. Transplant Proc 1995 0.75